Startup Profile: Lactiga (020)

Episode 20 • September 05, 2021 • 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 7

July 09, 2021 • 00:19:12
Episode Cover

Andrew Malloy on Family Office Impact Investing (007)

Andrew Malloy spent a career on Wall Street and also happens to be part of a 3rd generation family office created because of his...

Listen

Episode 1

January 10, 2022 • 00:16:07
Episode Cover

Amir Baluch, MD - Physician Side Hustle & Bio Wise Fund I & II (201)

Amir Baluch, MD, is an investor, serial entrepreneur, and fund manager at BioWise Capital. Dr. Baluch has ten years experience in private equity and...

Listen

Episode 1

May 28, 2021 • 00:03:52
Episode Cover

Innovation4Alpha Kick-Off (001)

This is a quick episode to describe what to expect from the Innovation4Alpha podcast hosted by Tobin Arthur.

Listen